Vaxil Bio Ltd. (VXL.V)
TSXV · CAD · Healthcare · Biotechnology
CA$0.13 (+0.00%) as of
Key statistics
- Market cap
- 517.92k
- P/E (TTM)
- 0.87
- EPS (TTM)
- 0.1500
- Dividend yield
- 0.00%
- 52-week range
- 0.1300 – 0.2900
- Beta
- -0.33
- Profit margin
- 0.00%
- Volume
- 500.00
About Vaxil Bio Ltd.
Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company is headquartered in Toronto, Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Toronto, ON, Canada
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.